ChemoCentryx, Inc. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ChemoCentryx, Inc. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 3.57 | 37,893 | 135,278 | 145,000 | |
| Jan 24 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Sell | S | 12.08 | 37,893 | 457,747 | 72,853 | 110.7 K to 72.9 K (-34.22 %) |
| Jan 24 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 3.57 | 37,893 | 135,278 | 110,746 | 72.9 K to 110.7 K (+52.01 %) |
| Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 36,762 | 220,572 | 160,000 | |
| Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.16 | 36,762 | 447,092 | 2,228,855 | 2.3 M to 2.2 M (-1.62 %) |
| Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 36,762 | 220,572 | 2,265,617 | 2.2 M to 2.3 M (+1.65 %) |
| Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 6,172 | 37,032 | 0 | |
| Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.00 | 6,172 | 74,079 | 35,441 | 41.6 K to 35.4 K (-14.83 %) |
| Jan 14 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 6,172 | 37,032 | 41,613 | 35.4 K to 41.6 K (+17.41 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 12,895 | 77,370 | 196,762 | |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 6.00 | 7,275 | 43,650 | 209,657 | |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 12,895 | 154,771 | 2,228,855 | 2.2 M to 2.2 M (-0.58 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 12,895 | 77,370 | 2,241,750 | 2.2 M to 2.2 M (+0.58 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.04 | 7,275 | 87,599 | 2,228,855 | 2.2 M to 2.2 M (-0.33 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 7,275 | 43,650 | 2,236,130 | 2.2 M to 2.2 M (+0.33 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 8,134 | 48,804 | 6,172 | |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 6.00 | 5,069 | 30,414 | 14,306 | |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.00 | 8,134 | 97,628 | 35,441 | 43.6 K to 35.4 K (-18.67 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 8,134 | 48,804 | 43,575 | 35.4 K to 43.6 K (+22.95 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.07 | 5,069 | 61,162 | 35,441 | 40.5 K to 35.4 K (-12.51 %) |
| Jan 09 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 6.00 | 5,069 | 30,414 | 40,510 | 35.4 K to 40.5 K (+14.30 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 60,000 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 33,334 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,334 | 0 | 0 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 10.91 | 52,806 | 576,113 | 2,228,855 | 2.3 M to 2.2 M (-2.31 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 2,281,661 | 2.3 M to 2.3 M (+1.33 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,251,661 | 2.2 M to 2.3 M (+1.50 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,334 | 0 | 2,218,328 | 2.2 M to 2.2 M (+1.53 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 13,333 | 0 | 13,334 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Payment of Exercise | F | 10.91 | 24,008 | 261,927 | 72,853 | 96.9 K to 72.9 K (-24.79 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 10,000 | 0 | 96,861 | 86.9 K to 96.9 K (+11.51 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 13,333 | 0 | 86,861 | 73.5 K to 86.9 K (+18.13 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | EVP, CFO and Sec. | Buy | M | 0.00 | 20,000 | 0 | 73,528 | 53.5 K to 73.5 K (+37.36 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Payment of Exercise | F | 10.91 | 8,716 | 95,092 | 10,614 | 19.3 K to 10.6 K (-45.09 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Buy | M | 0.00 | 5,000 | 0 | 19,330 | 14.3 K to 19.3 K (+34.89 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | SINGH RAJINDER | SVP, Research | Buy | M | 0.00 | 10,000 | 0 | 14,330 | 4.3 K to 14.3 K (+230.95 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 6,666 | 0 | 13,334 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.00 | 8,334 | 0 | 0 | |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Payment of Exercise | F | 10.91 | 13,385 | 146,030 | 35,441 | 48.8 K to 35.4 K (-27.41 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 6,666 | 0 | 48,826 | 42.2 K to 48.8 K (+15.81 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 10,000 | 0 | 42,160 | 32.2 K to 42.2 K (+31.09 %) |
| Jan 03 2019 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.00 | 8,334 | 0 | 32,160 | 23.8 K to 32.2 K (+34.98 %) |